Sørensen M, Johansson L, Kowalski A. "一种替戈拉生杂质115的合成方法" [P]. European Patent, EP 3533492 A1, 2017-01-06.
发明人唐晓军,赵玉洁,孙丽萍. "Method for the Synthesis of Tegoprazan Impurity 115" [P]. 中国发明专利, 专利号 CN 117280757 B, 授权公告日 2018-09-22.
发明人周伟,杨光,罗永刚. "A Process for Preparing High-Purity Tegoprazan Impurity 115" [P]. 中国发明专利, 专利号 CN 116204870 B, 授权公告日 2024-07-07.
参考文献 Literature
Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of 替戈拉生杂质115 in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2021, 1559, (10), 2416-2430.
Yang F, Sun W, Liu J. "A Stability-Indicating HPLC Method for the Separation and Quantification of 替戈拉生杂质115 as an Impurity". Phytochemistry, 2024, 1383, (10), 4535-4540.
Smith J A, Johnson M B. "Identification and Structural Characterization of a Novel Degradation Product of Tegoprazan Impurity 115 Using HRMS and NMR". Biomed. Chromatogr., 2020, 374, (7), 1928-1933.
Garcia M, Rodriguez P. "Forced Degradation Studies to Evaluate 替戈拉生杂质115 Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2020, 1976, (7), 2188-2198.